MétaCan
Menu
Back to cohort

Inhibition of Autophagy by Mevalonate Pathway Inhibitors, a New Therapeutic Approach to sensitize Glioblastoma Cells to Temozolomide Induced Apoptosis

2018· article· en· W3175396788 on OpenAlexaff
Shahla Shojaei, Javad Alizadeh, James A. Thliveris, Navid Koleini, Elissavet Kardami, Grant M. Hatch, Xu Fy, Sabine Hombach‐Klonisch, Thomas Klonisch, Saeid Ghavami

Bibliographic record

VenueThe FASEB Journal · 2018
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer, Lipids, and Metabolism
Canadian institutionsSt. Boniface HospitalUniversity of Manitoba
Fundersnot available
KeywordsTemozolomideAutophagyApoptosisStatinCancer researchSimvastatinMevalonate pathwayWestern blotCancer cellMedicineCancerPharmacologyChemistryGlioblastomaInternal medicineBiochemistryEnzyme

Abstract

fetched live from OpenAlex

Glioblastoma multiforme (GBM) is the deadliest brain tumor with an approximate 20 month survival rate after diagnosis and treatment. Temozolomide (TMZ), the chemotherapeutic drug of choice for GBM, is an alkylating agent that causes DNA damage. TMZ treatment results in the induction of apoptosis in GBM cells, however, it induces autophagy and consequently chemoresistance. Statins are mevalonate (MEV) cascade inhibitors with beneficial effects on the enhancement of the survival rate of patients with different types of cancer, particulary if consumed long term before diagnosis of cancer. Here, we determined the effect of simvastatin (Simva), a blood brain barrier permeable statin, on the sensitization of GBM cells to TMZ induced apoptosis through inhibition of autophagy flux. We pretreated two GMB cell lines, U251 and U87 cells, with low doses of Simva (1 and 2.5 μM, respectively) with or without different intermediates of the mevalonate cascade: MEV (2.5 mM), Farnesyl pyrophosphate (FPP) (15 μM), Geranylgeranyl pyrophosphate (GGPP) (15 μM) and cholesterol (50 μM) for 4 h and then treated cells with TMZ (100 μM) for 48–96 h. A signficiantly reduced viability and increase in the population of apoptotic dead cells were observed in GBM cells treated with the combination of Simva‐TMZ compared to cells treated with TMZ alone. Addition of MEV, FPP, GGPP and cholesterol did not attenuate these effects significantly. Sima‐TMZ treatment did not alter the total cholesterol pool in U87 and U251 cells compared to controls. Western blot analysis, immunocytochemistry and transmission electron microscopy revealed that the combination of Simva with TMZ inhibited autophagic flux. Overall, the results suggest that sensitization of GBM cells to TMZ‐induced apoptosis by Simva is independent on the cholesterol biosynthetic pathway but may involve inhibition of autophagy flux. Support or Funding Information Supported by funding from a Mitacs Accelerate PDF Award & a Health Science Center Foundation Operating Grant. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.002

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.232
Teacher spread0.221 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueThe FASEB JournalSame topicCancer, Lipids, and MetabolismFrench-language works237,207